Joint Clinical Practice Guideline On Benzodiazepine Tapering

The FDA-commissioned Joint Clinical Practice Guideline On Benzodiazepine Tapering comes from a collaboration of 10medical and professional societies, including the American Society of Addiction Medicine. One notable aspect is how centered it is to the patient experience: people with lived experience were closely involved in developing the guideline.